ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments

被引：0

作者：

Robado de Lope, L. ^{[1
]}

Serna-Blasco, R. ^{[1
]}

Mediavilla, P. ^{[1
]}

Sanz-Moreno, S. ^{[1
]}

Rodriguez-Festa, A. ^{[1
]}

Gallego-Gil, P. ^{[2
]}

Flores, C. ^{[1
]}

Calvo, V. ^{[2
]}

Collazo-Lorduy, A. ^{[2
]}

Blanco, M. ^{[2
]}

Pena Cabia, S. ^{[3
]}

Diz Tain, P. ^{[4
]}

Garrido Onecha, M. L. ^{[4
]}

Sanchez-Hernandez, A. ^{[5
]}

Sequero Lopez, S. ^{[6
]}

Rogado, J. ^{[7
]}

Coves Sarto, J. ^{[8
]}

Lopez Martin, A. ^{[3
]}

Mielgo, X. ^{[9
]}

Vazquez Estevez, S. ^{[10
]}

Gonzalez-Rumayor, V. ^{[11
]}

Romero, A. ^{[2
]}

Provencio, M. ^{[2
]}

机构：

[1] Inst Invest Sanitaria Puerta Hierro Segovia Arana, Majadahonda, Spain

[2] Hosp Univ Puerta Hierro Majadahonda, Majadahonda, Spain

[3] Hosp Univ Severo Ochoa, Leganes, Spain

[4] Complejo Asistencial Univ Leon, Leon, Spain

[5] Consorcio Hosp Prov Castellon, Castellon De La Plana, Spain

[6] Hosp Univ Clin San Cecilio, Granada, Spain

[7] Hosp Univ Infanta Leonor, Madrid, Spain

[8] Hosp Univ Son Llatzer, Palma de Mallorca, Spain

[9] Hosp Univ Fdn Alcorcon, Alcorcon, Spain

[10] Hosp Univ Lucus Augusti, Lugo, Spain

[11] Atrys Hlth, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Biomarkers; Immunotherapy; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.22-16

引用

页码：S252 / S252

页数：1

共 50 条

[31] Activating ERBB4 mutations in non-small cell lung cancer
K J Kurppa
K Denessiouk
M S Johnson
K Elenius
Oncogene, 2016, 35 : 1283 - 1291
[32] Activating ERBB4 mutations in non-small cell lung cancer
Kurppa, K. J.
Denessiouk, K.
Johnson, M. S.
Elenius, K.
ONCOGENE, 2016, 35 (10) : 1283 - 1291
[33] Different Types of ERBB3 Mutations in Chinese NonSmall Cell Lung Cancer Patients
Wang, Q.
Xu, C.
Wang, W.
Wang, D.
Zhu, Y.
Zhuang, W.
Fang, M.
Wang, G.
Song, Y.
Lu, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1215 - S1215
[34] Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
Shen, Jie
Gu, Linping
Qi, Yuwen
Yao, Yaxian
Lu, Shun
Chen, Zhiwei
FRONTIERS IN IMMUNOLOGY, 2023, 14
[35] Potential biomarkers for immunotherapy in non-small-cell lung cancer
Wang, Xing
Qiao, Ziyun
Aramini, Beatrice
Lin, Dong
Li, Xiaolong
Fan, Jiang
CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 661 - 675
[36] Potential biomarkers for immunotherapy in non-small-cell lung cancer
Xing Wang
Ziyun Qiao
Beatrice Aramini
Dong Lin
Xiaolong Li
Jiang Fan
Cancer and Metastasis Reviews, 2023, 42 : 661 - 675
[37] Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations
Brambilla, Marta
Beninato, Teresa
Piemontese, Anna
Mazzeo, Laura
Pircher, Chiara Carlotta
Manglaviti, Sara
Ambrosini, Paolo
Signorelli, Diego
Lorenzini, Daniele
Prelaj, Arsela
Ferrara, Roberto
Proto, Claudia
Lo Russo, Giuseppe
Pizzutilo, Elio Gregory
Ganzinelli, Monica
Grande, Ilaria
Capone, Iolanda
Di Mauro, Rosa Maria
Conca, Elena
Dumitrascu, Andra Diana
Zanella, Caterina
Leporati, Rita
Rota, Simone
Garassino, Marina Chiara
Marchetti, Paolo
de Braud, Filippo Maria
Occhipinti, Mario
CLINICAL LUNG CANCER, 2023, 24 (07) : 631 - +
[38] Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers
Park, Sang Wook
Chung, Nak Gyun
Han, Ji Youn
Eom, Hyeon Seok
Yoo, Nam Jin
Lee, Sug Hyung
APMIS, 2010, 118 (01) : 83 - 84
[39] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
Luecke, E.
Ganzert, C.
Waesche, A.
Walles, T.
Schreiber, J.
PNEUMOLOGIE, 2020, 74 : S74 - S75
[40] Dynamic Monitoring of Immunotherapy Effectiveness with Different Biomarkers in the Patients with Non-Small Cell Lung Cancer
Ganesh, Sridha
Wang, Rui
Chen, Honglei
ONCOLOGIE, 2021, 23 (03) : 335 - 350

← 1 2 3 4 5 →